• Portfolio

Oxford BioTherapeutics

Oxford BioTherapeutics is an oncology drug discovery business. By exploiting its proprietary database of human cell-surface proteins, it creates and develops novel targeted oncology therapeutics, with a focus on Antibody Drug Conjugates and Immune Oncology treatments.

Image for Oxford biotherapeutics - an oncology drug discovery business


Latest Oxford Capital News

Oxford Capital work with EISA to release new risk guide for ...

Changes to EIS prompts trade body EISA to release new risk guide for financial planners.

Read more

We’ve been shortlisted for the esteemed UKBAA Angel Invest...

Oxford Capital is proud to have been shortlisted for the prestigious

Read more

Not one, but TWO of our amazing portfolio companies feature ...

Dedicated to celebrating the positive impact entrepreneurs have on the British economy and society a...

Read more
More News